levodopa has been researched along with Glioblastoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, D; Bhunia, S; Chakravarty, S; Chaudhuri, A; Kuncha, M; Ravuri, HG; Sistla, R; Vangala, V | 1 |
| Aprile, C; Cavagnini, M; Ciocca, M; Facoetti, A; Lodola, L; Marenco, M; Nano, R; Orecchia, R; Pasi, F; Persico, MG; Valvo, F | 1 |
| Arntzen, KA; Bekkelund, SI; Lilleng, H | 1 |
| Khalil, R; Milandre, L | 1 |
4 other study(ies) available for levodopa and Glioblastoma
| Article | Year |
|---|---|
Large Amino Acid Transporter 1 Selective Liposomes of l-DOPA Functionalized Amphiphile for Combating Glioblastoma.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Blotting, Western; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Female; Flow Cytometry; Glioblastoma; Large Neutral Amino Acid-Transporter 1; Levodopa; Liposomes; Mice; Mice, Inbred C57BL; Spectrometry, Mass, Electrospray Ionization | 2017 |
Effects of L-DOPA Pretreatment on the Kinetics, Migration and Carbon Ion Radiation Response of T98G Cells.
Topics: Adult; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Radiation; Glioblastoma; Heavy Ion Radiotherapy; Humans; Kinetics; Levodopa | 2019 |
[Subacute worsening of rigidity in a patient with Parkinson disease].
Topics: Aged; Antiparkinson Agents; Brain Neoplasms; Disease Progression; Glioblastoma; Humans; Levodopa; Magnetic Resonance Imaging; Male; Muscle Rigidity; Muscle Spasticity; Parkinson Disease | 2008 |
[Tumoral Parkinson hemi-syndrome sensitive to L-dopa].
Topics: Benserazide; Brain Neoplasms; Drug Therapy, Combination; Glioblastoma; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease | 1994 |